Since the initial identification of C9orf72 hexanucleotide expansion mutations as the most common genetic cause of both FTD and ALS, a number of in vitro and in vivo models have been established in order to elucidate the molecular mechanism underpinning disease. Here, C9orf72 is linked to frontotemporal dementia.